Assoz. Prof. Mag. Dr. Anna Weinzinger, Privatdoz.
T: +43-1-4277-55311
21 - 40 out of 72
Qile M, Beekman HDM, Sprenkeler DJ, Houtman MJC, van Ham W, Weinzinger A et al. LUF7244, an allosteric modulator/activator of K(v)11.1 channels, counteracts dofetilide-induced torsades de pointes arrhythmia in the chronic atrioventricular block dog model. British Journal of Pharmacology. 2019 Oct 8;176(19):3871-3885. doi: 10.1111/bph.14798

Bernsteiner H, Plessl EM, Chen X, Weinzinger A. Conduction through a narrow inward-rectifier K+ channel pore. Journal of General Physiology. 2019 Sept.

Weinzinger A. Glibenclamide and HMR1098 normalize Cantú syndrome-associated gain-of-function currents. Journal of Cellular and Molecular Medicine. 2019 Aug;23(8):4962-4969. doi: 10.1111/jcmm.14329


Hellsberg E, Ecker G, Weinzinger A, Forrest LR. A structural model of the human serotonin transporter in an outward-occluded state. PLoS ONE. 2019 Jun 28;14(6):e0217377. doi: 10.1371/journal.pone.0217377

Chen X, Garon A, Wieder M, Houtman MJC, Zangerl-Plessl EM, Langer T et al. Computational identification of novel Kir6 channel inhibitors. Frontiers in Pharmacology. 2019 May;10:549. doi: 10.3389/fphar.2019.00549

Baburin I, Varkevisser R, Schramm A, Saxena P, Beyl S, Szkokan P et al. Dehydroevodiamine and hortiamine, alkaloids from the traditional Chinese herbal drug Evodia rutaecarpa, are I-Kr blockers with proarrhythmic effects in vitro and in vivo. Pharmacological Research. 2018 May;131:150-163. doi: 10.1016/j.phrs.2018.02.024

Cervenka R, Lukacs P, Gawali VS, Ke S, Koenig X, Rubi L et al. Distinct modulation of inactivation by a residue in the pore domain of voltage-gated Na+ channels: mechanistic insights from recent crystal structures. Scientific Reports. 2018 Jan 12;8(1):631. doi: 10.1038/s41598-017-18919-1

Gualdani R, Cavalluzzi MM, Tadini-Buoninsegni F, Convertino M, Gailly P, Stary-Weinzinger A et al. Molecular Insights into hERG Potassium Channel Blockade by Lubeluzole. Cellular Physiology and Biochemistry. 2018;45(6):2233-2245. doi: 10.1159/000488169

Cooper PE, McClenaghan C, Chen X, Stary-Weinzinger A, Nichols CG. Conserved functional consequences of disease-associated mutations in the slide helix of Kir6.1 and Kir6.2 subunits of the ATP-sensitive potassium channel. Journal of Biological Chemistry. 2017 Oct 20;292(42):17387-17398. doi: 10.1074/jbc.M117.804971

Gardner A, Wu W, Thomson S, Zangerl-Plessl EM, Stary-Weinzinger A, Sanguinetti MC. Molecular Basis of Altered hERG1 Channel Gating Induced by Ginsenoside Rg3. Molecular Pharmacology. 2017 Oct;92(4):437-450. doi: 10.1124/mol.117.108886

Ji Y, Veldhuis MG, Zandvoort J, Romunde FL, Houtman MJC, Duran K et al. PA-6 inhibits inward rectifier currents carried by V93I and D172N gain-of-function KIR2.1 channels, but increases channel protein expression. Journal of Biomedical Science. 2017 Jul 15;24(1):44. 44. doi: 10.1186/s12929-017-0352-x

Bernsteiner H, Bründl M, Stary-Weinzinger A. Dynamics of the EAG1 K+ channel selectivity filter assessed by molecular dynamics simulations. Biochemical and Biophysical Research Communications. 2017 Feb 26;484(1):107-112. doi: 10.1016/j.bbrc.2017.01.064

Saxena P, Zangerl-Plessl EM, Linder T, Windisch A, Hohaus A, Timin E et al. New potential binding determinant for hERG channel inhibitors. Scientific Reports. 2016 Apr 12;6:24182. doi: 10.1038/srep24182

Linder T, Bernsteiner H, Saxena P, Bauer F, Erker T, Timin E et al. Drug trapping in hERG K+ channels: (Not) a matter of drug size? MedChemComm. 2016 Mar 1;7(3):512-518. doi: 10.1039/c5md00443h

Lee SJ, Ren F, Zangerl-Plessl EM, Heyman S, Stary-Weinzinger A, Yuan P et al. Structural basis of control of inward rectifier Kir2 channel gating by bulk anionic phospholipids. Journal of General Physiology. 2016;148(3):227-237. doi: 10.1085/jgp.201611616

Linder T, Wang S, Plessl EM, Nichols CG, Weinzinger A. Molecular Dynamics Simulations of KirBac1.1 Mutants Reveal Global Gating Changes of Kir Channels. Journal of Chemical Information and Modeling. 2015 Mar 20;55(4):814–822. doi: 10.1021/acs.jcim.5b00010

Linder T, Saxena P, Timin E, Hering S, Weinzinger A. Structural Insights into Trapping and Dissociation of Small Molecules in K+ Channels. Journal of Chemical Information and Modeling. 2014 Nov;54(11):3218-3228. doi: 10.1021/ci500353r


Thurner P, Stary-Weinzinger A, Gafar H, Gawali VS, Kudlacek O, Zezula J et al. Mechanism of hERG channel block by the psychoactive indole alkaloid ibogaine. Journal of Pharmacology and Experimental Therapeutics. 2014 Feb;348(2):346-358. doi: 10.1124/jpet.113.209643

21 - 40 out of 72

Allosteric control of GIRK channels: insights from channelopathies and drug modulation

Weinzinger, A. (Speaker)

Mar 2026

Activity: Talks and presentationsTalk or oral contributionScience to Science


Ion Channels in Health and Disease: From Mechanistic Understanding to Therapeutic Solutions

Weinzinger, A. (Speaker)

16 Sept 2025

Activity: Talks and presentationsTalk or oral contributionScience to Science


GNB1: Mutations, Protein Interactions, and Drug Repurposing

Weinzinger, A. (Speaker)

24 Jun 2025

Activity: Talks and presentationsTalk or oral contributionScience to Public


GIRK2 DRUG REPURPOSING SCREEN IDENTIFIES TREATMENT OPTIONS FOR PATIENTS SUFFERING FROM EXTREMELY RARE DISEASES

Netzer, M. (Speaker), Hering, S. (Contributor), Dascal, N. (Contributor) & Weinzinger, A. (Contributor)

16 Feb 2025

Activity: Talks and presentationsTalk or oral contributionScience to Science


Allosteric mechanisms of inward rectifier K+ channel gating probed by disease mutants and ethosuximide

Weinzinger, A. (Speaker)

12 Sept 2024

Activity: Talks and presentationsTalk or oral contributionScience to Science


Allosteric regulation of GIRK K+ channels

Weinzinger, A. (Speaker)

9 Jul 2024

Activity: Talks and presentationsTalk or oral contributionScience to Science


Allosteric mechanisms of inward rectifier K+ channel gating

Weinzinger, A. (Speaker)

23 Jun 2024

Activity: Talks and presentationsTalk or oral contributionScience to Science


Challenges in drug repurposing for rare diseases – the GNB1/KCNJ6 example

Weinzinger, A. (Speaker)

12 Sept 2023

Activity: Talks and presentationsTalk or oral contributionScience to Science


Probing Inward Rectifier K+ Channel Gating and Conductance Guided by Disease Mutations

Weinzinger, A. (Speaker)

21 Jun 2023

Activity: Talks and presentationsTalk or oral contributionScience to Science


Computational investigation of a rare disease

Friesacher, T. (Speaker) & Weinzinger, A. (Contributor)

Sept 2022 → …

Activity: Talks and presentationsTalk or oral contributionScience to Science


Visualizing individual protonation events in Kir2 channels

Jirout, M. (Speaker), Zangerl-Plessl, E. M. (Contributor) & Weinzinger, A. (Contributor)

Sept 2022 → …

Activity: Talks and presentationsTalk or oral contributionScience to Science


Computational investigations of ion channels

Weinzinger, A. (Speaker)

15 Sept 201920 Sept 2019

Activity: Talks and presentationsTalk or oral contributionScience to Science


FASEB: The Ion Channel Regulation Conference: Molecules to Disease

Weinzinger, A. (Speaker)

7 Jul 201912 Jul 2019

Activity: Talks and presentationsTalk or oral contributionScience to Science


Structure-dynamics-function relationships of inward rectifier K+ channels probed by in silico methods

Weinzinger, A. (Speaker)

27 Mar 2018

Activity: Talks and presentationsTalk or oral contributionScience to Science


Computational investigations of cation channels

Weinzinger, A. (Speaker)

19 May 2017

Activity: Talks and presentationsTalk or oral contributionScience to Science


In silico modelling and drug interactions in Kir6.1

Weinzinger, A. (Speaker)

4 Oct 2016

Activity: Talks and presentationsTalk or oral contributionOther


Molecular modeling of Cantu Syndrome Channels

Weinzinger, A. (Speaker)

10 Sept 2015

Activity: Talks and presentationsTalk or oral contributionOther


Computational investigations of hERG K+ channels

Weinzinger, A. (Speaker)

10 Aug 2015

Activity: Talks and presentationsTalk or oral contributionOther


MD SIMULATIONS OF KIRBAC1.1 MUTANTS REVEAL GATING CHANGES AT THE BUNDLE CROSSING REGION

Weinzinger, A. (Speaker)

4 Feb 2013

Activity: Talks and presentationsTalk or oral contributionOther


Investigating the structural basis of hERG channel block guided by molecular dynamics simulations

Weinzinger, A. (Speaker)

25 Sept 2012

Activity: Talks and presentationsTalk or oral contributionOther


In silico modelling of Kir2.x channels

Weinzinger, A. (Speaker)

2011 → …

Activity: Talks and presentationsTalk or oral contributionScience to Science


IK1 block by small molecules

Weinzinger, A. (Speaker)

2010 → …

Activity: Talks and presentationsTalk or oral contributionOther


In silico prediction of the cardiotoxicity of drug candidates

Weinzinger, A. (Speaker)

2008 → …

Activity: Talks and presentationsTalk or oral contributionScience to Science


Modelling the hERG K+ channel

Weinzinger, A. (Speaker)

2008 → …

Activity: Talks and presentationsTalk or oral contributionScience to Science


Towards a consensus model of the hERG K+ channel

Weinzinger, A. (Speaker)

2008 → …

Activity: Talks and presentationsTalk or oral contributionOther


Computer modeling strategies to investigate the molecular basis of odor discrimination

Weinzinger, A. (Speaker)

2006 → …

Activity: Talks and presentationsTalk or oral contributionScience to Science


Novel approaches to investigate the regulation of G-protein coupled inward rectifier K+ channels by Gβγ

Weinzinger, A. (Project Lead) & Friesacher, T. (Co-Lead)

1/08/2131/07/24

Project: Research funding


PROSTAGLANDINES - POTENTIAL THERAPEUTICS FOR DEND SYNDROME?

Weinzinger, A. (Project Lead)

1/12/2030/07/23

Project: Research funding


Sulfonylharnstoffe

Weinzinger, A. (Project Lead)

1/03/1528/02/19

Project: Research funding


hERG K+ Channel activators

Weinzinger, A. (Project Lead)

4/11/144/11/15

Project: Research funding


hEAG1 channel blockers

Weinzinger, A. (Project Lead)

15/03/1414/03/15

Project: Research funding


Molecular Drug Targets

Hering, S. (Project Lead), Ecker, G. (Co-Lead), Maulide, N. (Co-Lead), Weinzinger, A. (Co-Lead) & Gonzalez Herrero, L. (Co-Lead)

1/12/1031/12/22

Project: Research funding


hERG potassium channel

Weinzinger, A. (Project Lead)

27/10/1031/12/11

Project: Research funding


Department of Pharmaceutical Sciences

Josef-Holaubek-Platz 2 (UZA II)
1090 Wien
Room: 2D178

T: +43-1-4277-55311

anna.stary@univie.ac.at